HSPB1

HSPB1 Full Name

heat shock 27kDa protein 1

HSPB1 Introduction

Heat shock protein beta-1 (HSPB1), also known as heat shock 27 kDa protein 1 or HSP27, is a member of the small heat shock protein (sHSP) family that plays a critical role in cellular stress adaptation. In many biological and clinical research settings, investigators face the challenge of understanding how cells survive under harsh conditions such as oxidative stress, inflammation, and protein misfolding. HSPB1 acts as a molecular chaperone that helps maintain protein homeostasis by preventing the aggregation of damaged or misfolded proteins and stabilizing cytoskeletal components. It is widely expressed in human tissues and becomes rapidly upregulated in response to environmental stresses including heat shock, hypoxia, and chemical injury. Through its dynamic phosphorylation-dependent oligomerization, HSPB1 participates in multiple signaling pathways that regulate apoptosis, cytoskeletal organization, and cellular survival, making it an important molecular target in studies of stress biology and disease progression.

Functionally, HSPB1 has been shown to influence key cellular processes such as apoptosis resistance, oxidative stress defense, and protein quality control. Its anti-apoptotic activity is particularly relevant in disease contexts where abnormal cell survival contributes to pathology. HSPB1 can interact with components of apoptotic signaling pathways, inhibit caspase activation, and modulate reactive oxygen species (ROS) levels, thereby protecting cells from stress-induced death. Recent research has further expanded its functional landscape, demonstrating that HSPB1 participates in signaling networks involving kinases and transcriptional regulators. For example, studies have reported that the FYN/TOPK/HSPB1 signaling axis significantly enhances proliferation and metastatic potential in gastric cancer cells, highlighting the role of HSPB1 as a downstream effector in oncogenic kinase signaling. Additionally, emerging evidence indicates that HSPB1 can regulate ferroptosis pathways by influencing the TP53/SLC7A11/GPX4 signaling cascade, suggesting that it plays an important role in controlling lipid peroxidation and iron-dependent cell death mechanisms.

The clinical relevance of HSPB1 continues to grow as new studies reveal its involvement in a wide spectrum of diseases. In oncology, elevated HSPB1 expression has been linked to tumor progression, metastasis, and treatment resistance in several cancers, including gastric and pancreatic cancer, making it a promising biomarker and therapeutic target. In pancreatic cancer, overexpression of HSPB1 has been reported to suppress ferroptosis and promote tumor survival by modulating TP53-dependent pathways, which may contribute to therapy resistance and disease aggressiveness. Beyond cancer, genetic variants in the HSPB1 gene have been associated with neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS), where rare mutations may disrupt protein homeostasis and neuronal survival. Recent research has also uncovered an unexpected role for HSPB1 in osteoarthritis, demonstrating that the protein can bind RNA molecules and regulate inflammatory and metabolic responses in chondrocytes. Together, these findings highlight HSPB1 as a multifunctional stress-response protein with significant implications for cancer biology, neurodegeneration, and inflammatory diseases, underscoring its growing importance as a target for biomedical research and therapeutic development.

Alternate Names for HSPB1

HSPB1; heat shock 27kDa protein 1; CMT2F; HMN2B; HSP27; HSP28; Hsp25; SRP27; HS.76067; HEL-S-102

• 1.Peng S, et al.; FYN/TOPK/HSPB1 axis facilitates the proliferation and metastasis of gastric cancer. J Exp Clin Cancer Res. 2023, 42(1):80.
  2.Yang Y, et al.; The role of HSPB1 in modulating ferroptosis in pancreatic cancer via the TP53/SLC7A11/GPX4 axis. Cell Death Dis. 2025, 14:434.